Does Rivian's AI-Driven RAP Provide It a Competitive Edge?
Rivian RIVN, an American EV manufacturer, has created its advanced driver assistance system (ADAS), known as the Rivian Autonomy Platform (RAP). This in-house platform features a more powerful computing system than that used in Rivian's earlier vehicles and is tailored specifically for its current and future models.
RAP provides Level 2+ autonomy, meaning it supports the driver with alerts and interventions, such as steering corrections and emergency braking, but it never takes full control of the vehicle. The system includes a comprehensive set of ADAS tools, stepping in only when necessary.
Standard on the R1T and R1S models, RAP's features fall into two main categories: Driving Assist and Active Safety Assist. Driving Assist includes user-activated tools like Highway Assist, Adaptive Cruise Control and Lane-Change Assistance. Active Safety Assist includes automatic features aimed at preventing accidents, such as lane safety, lighting adjustments, parking and reversing aids, and collision mitigation. RIVN carries a Zacks Rank #2 (Buy) at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.
With the introduction of its second-generation R1 platform, Rivian has significantly upgraded RAP. The vehicles now use a revamped perception system and computing setup, including 55-megapixel cameras and onboard processing power exceeding 200 trillion operations per second. The platform's AI-driven design and vertically integrated hardware allow Rivian to efficiently collect and process high-quality, multi-modal sensor data, giving it a competitive edge in ADAS development. Other automakers like Toyota Motor Corporation TM and Waymo, a subsidiary of Alphabet Inc. GOOGL, and Tesla TSLA are also making progress on the development of their respective autonomous vehicle platforms.
In April, Toyota and GOOGL's Waymo reached a preliminary agreement to explore a collaboration focused on the development of a new autonomous vehicle platform. Toyota and GOOGL's Waymo aim to combine their respective strengths to develop the platform. In parallel, the companies will explore how to leverage Waymo's autonomous technology and Toyota's vehicle expertise to enhance next-generation personally owned vehicles.
Tesla's Full Self-Driving (FSD) system is a sophisticated driver-assistance technology designed to allow Tesla cars to navigate various driving conditions autonomously. FSD builds on Tesla's existing Autopilot features and is sold as an optional upgrade. The company has long been a leader in autonomous vehicle development. Tesla released its last major FSD update, v13, in December 2024.
Rivian's Price Performance, Valuation and Estimates
Rivian has outperformed the Zacks Automotive-Domestic industry year-to-date. RIVN shares have gained 4.6% against the industry's decline of 18.3%.
YTD Price Performance
From a valuation perspective, Rivian appears undervalued. Going by its price/sales ratio, the company is trading at a forward sales multiple of 2.47, lower than its industry's 2.64.
EPS Estimates Revision
The Zacks Consensus Estimate for 2025 and 2026 EPS has moved down 3 cents and up 2 cents, respectively, in the past 30 days.
Image Source: Zacks Investment Research
7 Best Stocks for the Next 30 Days
Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."
Since 1988, the full list has beaten the market more than 2X over with an average gain of +23.5% per year. So be sure to give these hand picked 7 your immediate attention.
See them now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Toyota Motor Corporation (TM): Free Stock Analysis Report
Tesla, Inc. (TSLA): Free Stock Analysis Report
Alphabet Inc. (GOOGL): Free Stock Analysis Report
Rivian Automotive, Inc. (RIVN): Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
an hour ago
- Globe and Mail
Viking Therapeutics Stock (VKTX): This Underrated Russell 2000 Gem Could Skyrocket 200%
Viking Therapeutics (VKTX) is quickly emerging as one of the most promising biotech stocks in the small-cap Russell 2000 index. With Wall Street analysts projecting a potential upside of over 200%, the stock has captured the attention of growth-focused investors. Backed by a strong pipeline targeting obesity and liver diseases, Viking's innovative therapies could pave the way for major breakthroughs and significant shareholder returns. Confident Investing Starts Here: VKTX's Bullish Case Viking Therapeutics is a clinical-stage biotechnology company focused on developing innovative therapies targeting metabolic and endocrine disorders. Their pipeline includes promising candidates for treating obesity, non-alcoholic fatty liver disease (NAFLD), and muscle wasting. Understandably, clinical-stage biotech firms come with high risk. Their treatments might never make it through trials or reach the market, and even if they do, profits aren't guaranteed. The company currently has no approved products, no revenue, and runs at a loss. During times of market uncertainty, investors often shy away from companies like this. However, Viking Therapeutics stands out from many other biotech firms. It's working on treatments for several major health issues, especially in areas where better options are needed. One key focus is weight loss, a market that's been growing fast and still has a lot of room to expand. Viking's top drug candidate, VK2735, targets both GLP-1 and GIP receptors, a combination found in Eli Lilly's (LLY) Zepbound, the current market leader and only approved drug of its kind so far. Additionally, the company is seeing encouraging results from its mid-stage program VK2809, aimed at treating metabolic dysfunction-associated steatohepatitis (MASH). For context, MASH is a liver disease linked to obesity and becoming increasingly common. While the FDA only approved the first treatment for MASH last year, more approvals are expected shortly. Is Viking Therapeutics a Good Stock to Buy? Viking Therapeutics stock carries high risk, making it unsuitable for cautious investors. However, for those comfortable with volatility, a small position could offer strong long-term upside while limiting potential losses if the company fails. According to TipRanks, VKTX stock has received a Strong Buy consensus rating, with 13 Buys and one Hold assigned in the last three months. The average Viking Therapeutics stock price target is $90.7, suggesting a potential upside of nearly 217.32% from the current level. Year-to-date, VKTX stock has declined by almost 30%. See more VKTX analyst ratings
Globe and Mail
an hour ago
- Globe and Mail
Billionaire Bill Ackman Just Joined Warren Buffett and Cathie Wood by Adding This Monster Artificial Intelligence (AI) Stock to His Portfolio
Bill Ackman is a billionaire hedge fund manager as CEO of Pershing Square Capital Management. Unlike many of his peers on Wall Street, Ackman primarily keeps a tightly concentrated portfolio, with Pershing Square owning only about 10 stocks at any given time. For the last couple of years, Pershing Square's most direct artificial intelligence (AI) investment has been a sizable position in Alphabet. Ackman has made it clear that its diversified ecosystem -- spanning internet search, cloud computing, advertising, cybersecurity, and more -- combined with an attractive valuation is what enticed Pershing Square to take a position in the "Magnificent Seven" member. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Well, just a few weeks ago, news broke that Pershing Square had recently initiated a position in another AI stock, Amazon (NASDAQ: AMZN). Ackman now joins Warren Buffett, whom he is known to admire, and Cathie Wood as prominent personalities on Wall Street who have exposure to Amazon, through their respective portfolios at Berkshire Hathaway and ARK Invest. Let's explore what makes Amazon such a compelling AI stock for the long haul. I'll break down some trends in the business and the company's valuation to help explain why Amazon has earned the approval of Ackman, Buffett, and Wood. Amazon has a compelling AI narrative and... Given how hot AI has become, investors may be challenged to identify which opportunities are best suited for long-term positions. What I mean by that is while semiconductor stocks or AI software businesses have risen in popularity over the last couple of years, it's hard to know which of these companies will continue to be a market leader in 10 years (or longer). To me, Amazon is like the business version of a Swiss Army knife. The company's core segments are e-commerce and cloud computing infrastructure via Amazon Web Services (AWS). But it also has a thriving advertising business and a growing subscription service (Amazon Prime), and it has even made some progress in the streaming and entertainment landscape. Similar to Alphabet, Amazon is uniquely positioned to stitch its various operating units together through more AI-powered services. In essence, by leveraging the power of AI, it can bolster both the consumer and enterprise sides of its business and make the platform increasingly sticky for its customers. ... the company's investments are already bearing fruit While the ideas above sound great in theory, let's explore how the business has performed over the last couple of years since it started investing aggressively in AI. The first headline-grabbing move it made in AI was its investment in OpenAI rival Anthropic. The thesis around this partnership was to train Anthropic's generative AI model on AWS -- essentially integrating the efficiency of large language models into the AWS platform. Anthropic also agreed to use Amazon's in-house Trainium and Inferentia chipsets, providing the company with a direct avenue to begin scaling up a new part of its existing hardware business. Since Anthropic joined forces with Amazon, AWS revenue has accelerated considerably. But more important, operating income from Amazon's cloud business has almost doubled! AMZN Cash from Operations (TTM) data by YCharts; TTM = trailing 12 months. When you consider that Amazon's AI-driven growth is primarily sourced through just the cloud business right now, it becomes clearer that the company can leverage its robust profitability to reinvest in other areas of its business and jump-start those, too. I think that comes into focus as Wall Street's consensus revenue and earnings estimates over the next few years suggest there is much more growth ahead. AMZN Revenue Estimates for Current Fiscal Year, data by YCharts; EPS = earnings per share. Is Amazon a buy right now? Like many of its peers in the technology sector, Amazon has enjoyed a bit of a roller coaster ride so far this year. Shares bottomed at roughly $167 in April, which is likely when Ackman pounced. I say that because Pershing Square's position in Amazon was not included in the company's form 13F filing for the first quarter (ended March 31). If you had bought the dip in Amazon when Ackman did, you would have paid around 27 times forward earnings. AMZN PE Ratio (Forward) data by YCharts; PE = price to earnings. Among the 70 analysts who cover the stock, 66 rate it as either a buy or strong buy. Furthermore, with an average price target of $239, Wall Street's estimates imply there is still some modest upside. While Amazon's valuation has expanded over the last month and a half, the company's long-run prospects and added AI-centric uses still make it a reasonable buy in my view. Should you invest $1,000 in Amazon right now? Before you buy stock in Amazon, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Amazon wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $653,702!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $870,207!* Now, it's worth noting Stock Advisor 's total average return is988% — a market-crushing outperformance compared to172%for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of June 9, 2025 John Mackey, former CEO of Whole Foods Market, an Amazon subsidiary, is a member of The Motley Fool's board of directors. Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool's board of directors. Adam Spatacco has positions in Alphabet and Amazon. The Motley Fool has positions in and recommends Alphabet, Amazon, and Berkshire Hathaway. The Motley Fool has a disclosure policy.
Globe and Mail
2 hours ago
- Globe and Mail
Craig Izenstark Launches Scholarship to Support Future Leaders in Finance and Technology
Boca Raton, Florida--(Newsfile Corp. - June 14, 2025) - In a commitment to empowering the next generation of financial and technology leaders, Craig Izenstark has launched the Craig Izenstark Scholarship, a new initiative designed to support high-achieving students pursuing careers in finance, economics, data science, and related fields. To view an enhanced version of this graphic, please visit: With a belief that access to education is the foundation for lasting innovation and leadership, the scholarship program offers financial assistance to students who demonstrate academic excellence, personal integrity, and a vision for creating positive change in their chosen industries. "I've been fortunate to build a career in finance, but I recognize that not every talented student has the same opportunities," said Craig Izenstark. "This scholarship is my way of helping to level the playing field and invest in individuals who will drive progress in the future." The Craig Izenstark Scholarship is open to students across the United States. Applicants are required to submit a short essay that highlights their goals, achievements, and how they plan to contribute meaningfully to their field of study or community. The winner will receive a $1,000 award to help support their educational journey. Beyond financial support, the scholarship reflects Izenstark's broader mission to promote ethical leadership, innovation, and education in today's fast-changing economy. He believes that mentorship, opportunity, and access to resources are key drivers of long-term impact. The scholarship has already drawn interest from aspiring students eager to share their stories and gain support for their academic ambitions. How to Apply Students can learn more about eligibility requirements and apply through the official website: The application deadline and details are available on the site.
